News Results for Genus (GNS)

  • 07 Dec
    08:23
    Genus raises £68m through placing of shares

    Animal genetics company Genus said Friday it had raised gross proceeds of £68m from the placing of shares. The company issued a total of 3,097,200 shares at a price of 2,200p a share, raising...

  • 07 Dec
    08:20
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today upgrades its investment rating on Genus PLC (LON:GNS) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

  • 06 Dec
    10:00
    Broker Forecast - Kepler Cheuvreux issues a broker note on Genus PLC

    Kepler Cheuvreux today upgrades its investment rating on Genus PLC (LON:GNS) to buy (from hold) and raised its price target to 2630p (from 2475p). Story provided by StockMarketWire.com Broker...

  • 15 Nov
    09:12
    Genus profits hurt by weaker porcine business amid swine fever breakout in China

    Animal genetics company Genus reported Thursday lower profits after its porcine business continued to face challenging conditions following the African Swine Fever breakout across China. But the...

  • 12 Oct
    08:00
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today downgrades its investment rating on Genus PLC (LON:GNS) to hold (from buy). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

  • 03 Oct
    08:00
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today upgrades its investment rating on Genus PLC (LON:GNS) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

  • 19 Sep
    17:50
    Director Deals - Genus PLC (GNS)

    Stephen Wilson, Financial Director, exercised 40,639 shares in the company on the 14th September 2018 at a price of 0.00p. The Director now holds 79,613 shares. Story provided by...

  • 19 Sep
    17:50
    Director Deals - Genus PLC (GNS)

    Stephen Wilson, Financial Director, sold post-exercise 20,170 shares in the company on the 18th September 2018 at a price of 2536.00p. The Director now holds 59,443 shares. NOTE: Sold to meet tax...

  • 18 Sep
    17:55
    Director Deals - Genus PLC (GNS)

    Karim Bitar, Chief Executive Officer, exercised 56,083 shares in the company on the 17th September 2018 at a price of 0.00p. The Director now holds 124,296 shares. Story provided by...

  • 18 Sep
    17:55
    Director Deals - Genus PLC (GNS)

    Karim Bitar, Chief Executive Officer, exercised 56,083 shares in the company on the 17th September 2018 at a price of 0.00p. The Director now holds 124,296 shares. Story provided by...

  • 07 Sep
    14:10
    Broker Forecast - Kepler Cheuvreux issues a broker note on Genus PLC

    Kepler Cheuvreux today reaffirms its hold investment rating on Genus PLC (LON:GNS) and raised its price target to 2540p (from 2470p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 06 Sep
    12:05
    FTSE flat as rising utilities fail to offset falling miners

    The FTSE 100 fell into the red as rising utilities was offset by declining mining stocks. Glencore shed 1.4% to 307.6p and Antofagasta retreated 1% to 788.4p. Energy providers Centrica and SSE...

  • 06 Sep
    09:00
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today downgrades its investment rating on Genus PLC (LON:GNS) to hold (from buy) and set its price target at 2600p. Story provided by StockMarketWire.com Broker Forecasts data provided...

  • 06 Sep
    08:31
    Genus profits slump on biological assets write down; shares nosedive

    Animal genetics company Genus saw its share price nosedive Thursday after statutory profit slumped sharply as it wrote down its biological assets. For the year ended 30 June 2018, statutory...

  • 06 Sep
    08:30
    Broker Forecast - Liberum Capital issues a broker note on Genus PLC

    Liberum Capital today reaffirms its hold investment rating on Genus PLC (LON:GNS) and set its price target at 2400p. Story provided by StockMarketWire.com Broker Forecasts data provided by...

  • 04 Jul
    09:10
    Broker Forecast - Kepler Cheuvreux issues a broker note on Genus PLC

    Kepler Cheuvreux today reaffirms its hold investment rating on Genus PLC (LON:GNS) and raised its price target to 2470p (from 2353p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 12 Jun
    15:55
    Director Deals - Genus PLC (GNS)

    Lesley Knox, Non Executive Director, bought 2,000 shares in the company on the 11th June 2018 at a price of 2670.00p. The Director now holds 2,000 shares representing 0.00% of the shares in issue....

  • 04 Apr
    11:40
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today reaffirms its buy investment rating on Genus PLC (LON:GNS) and set its price target at 2600p. Story provided by StockMarketWire.com Broker Forecasts data provided by...

  • 16 Mar
    14:55
    Director Deals - Genus PLC (GNS)

    Karim Bitar, Chief Executive Officer, sold 35,803 shares in the company on the 16th March 2018 at a price of 2330.00p. The Director now holds 68,213 shares. Story provided by StockMarketWire.com...

  • 28 Feb
    17:03
    FTSE declines on weak miners

    The FTSE 100 was struggling for direction as miners weakened on soft manufacturing data from China. Antofagasta (ANTO) shed 3.9% to 870p and Fresnillo (FRES) fell 4.2% to £12.19. Miner Rio Tinto...

  • 28 Feb
    11:59
    FTSE falls on weak Chinese manufacturing data

    Miners dragged the FTSE 100 into negative territory following soft manufacturing data from China. The FTSE 100 traded 0.2% lower at 7,265 around midday. Rio Tinto (RIO) and BHP Billiton (BLT) were...

  • 28 Feb
    09:35
    Genus profits up 16% amid improving market conditions

    Genus reported pre-tax profits of £29m for the six months to the end of December, up 16% at actual currencies and 20% on a constant currency basis. The strong performance was helped by the launch...

  • 14 Feb
    08:00
    Broker Forecast - Liberum Capital issues a broker note on Genus PLC

    Liberum Capital today reaffirms its hold investment rating on Genus PLC (LON:GNS) and raised its price target to 2400p (from 2100p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 16 Nov
    15:00
    All resolutions passed at AGM of Genus

    Genus has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 3:00pm: (LON:GNS) Genus PLC share price was -4.5p at 2212.5p Story provided by...

  • 16 Nov
    07:48
    Genus in line with forecasts

    Genus has traded in line with forecasts since the beginning of July and continued to make good progress towards its strategic objectives for the year, according to an update issued ahead of today's...

  • 07 Nov
    10:40
    Broker Forecast - Kepler Cheuvreux issues a broker note on Genus PLC

    Kepler Cheuvreux today initiates coverage of Genus PLC (LON:GNS) with a hold investment rating and price target of 2353p. Story provided by StockMarketWire.com

  • 02 Nov
    14:06
    Genus non-exec to step down

    Genus has announced that Duncan Maskell, Non-Executive Director, intends to step down from the Board, effective from the 2018 Annual General Meeting. At 2:06pm: (LON:GNS) Genus PLC share price...

  • 12 Oct
    14:25
    Genus schedules AGM

    Genus has confirmed that the Company intends to hold its Annual General Meeting on 16 November. At 2:25pm: (LON:GNS) Genus PLC share price was -12p at 2211p Story provided by...

  • 13 Sep
    08:00
    Broker Forecast - Liberum Capital issues a broker note on Genus PLC

    Liberum Capital today downgrades its investment rating on Genus PLC (LON:GNS) to hold (from buy) and raised its price target to 2100p (from 1950p). Story provided by StockMarketWire.com

  • 09 Jun
    17:07
    FTSE rally continues as May focuses on creating a minority government

    UK Prime Minister Theresa May said she was aiming to form a minority government with the backing of the Democratic Unionist Party (DUP) after the general election resulted in a hung parliament....

  • 09 Jun
    12:01
    Pound falls on unexpected hung parliament result

    It was a dramatic end to the week as the UK general election resulted in a hung parliament as the Conservatives failed to win the required 326 seats for a majority. Despite losing more seats than...

  • 09 Jun
    07:59
    Genus facing new patent infringement litigation

    Genus is facing new patent infringement litigation in the US. The company - a global pioneer in animal genetics - said Inguran, XY and Cytonome/ST, (collectively ST) had filed patent...

  • 09 Jun
    07:08
    FLASH: Genus update on US litigation

    Story provided by StockMarketWire.com

  • 01 Jun
    07:51
    Genus update on Milk Pension Fund

    Genus, a leading global animal genetics company, has noted an announcement by National Milk Records regarding its proposed withdrawal from the Milk Pension Fund under a flexible apportionment...

  • 01 Jun
    07:08
    FLASH: Genus update on Milk Pension Fund

    Story provided by StockMarketWire.com

  • 04 Apr
    15:50
    Broker Forecast - Numis issues a broker note on Genus PLC

    Numis today reaffirms its hold investment rating on Genus PLC (LON:GNS) and set its price target at 1815p. Story provided by StockMarketWire.com

  • 03 Apr
    11:00
    Broker Forecast - N+1 Singer issues a broker note on Genus PLC

    N+1 Singer today reaffirms its hold investment rating on Genus PLC (LON:GNS) and set its price target at 1844p. Story provided by StockMarketWire.com

  • 03 Apr
    07:41
    Genus granted injunction against Inguran

    Genus has been awarded an injunction in its favour in connection with its litigation against Inguran LLC, operating as Sexing Technologies. Genus said that in granting the permanent injunction in...

  • 03 Apr
    07:13
    FLASH: Genus wins litigation against Inguran

    Story provided by StockMarketWire.com

  • 23 Mar
    09:30
    Broker Forecast - Berenberg issues a broker note on Genus PLC

    Berenberg today initiates coverage of Genus PLC (LON:GNS) with a hold investment rating and price target of 1800p. Story provided by StockMarketWire.com

  • 02 Mar
    11:10
    Broker Forecast - Liberum Capital issues a broker note on Genus PLC

    Liberum Capital today upgrades its investment rating on Genus PLC (LON:GNS) to buy (from hold) and left its price target at 1950p. Story provided by StockMarketWire.com

  • 23 Feb
    08:18
    Genus hikes divi as revenues rise

    Genus, a leading animal genetics company, reports adjusted pre-tax profits of £25.1m for the six months to the end of December - 5% up at actual currency but 10% down on a constant currency basis....

  • 23 Feb
    07:10
    FLASH: Genus revenues up

    Story provided by StockMarketWire.com

  • 17 Nov
    14:18
    Genus resolutions passed at AGM

    Genus has confirmed that all resolutions proposed at its annual general meeting today were passed At 2:18pm: (LON:GNS) Genus PLC share price was -20p at 1923p Story provided by...

  • 20 Sep
    14:50
    Broker Forecast - N+1 Singer issues a broker note on Genus PLC

    N+1 Singer today upgrades its investment rating on Genus PLC (LON:GNS) to hold (from sell) and raised its price target to 2019p (from 1429p). Story provided by StockMarketWire.com

  • 09 Sep
    16:10
    Broker Forecast - Liberum Capital issues a broker note on Genus PLC

    Liberum Capital today downgrades its investment rating on Genus PLC (LON:GNS) to hold (from buy) and set its price target at 1950p. Story provided by StockMarketWire.com

  • 08 Sep
    07:38
    Genus adjusted pre-tax profits up

    Genus, a leading global animal genetics company, reports significant strategic progress and continued profit growth in the year to the end of June. Adjusted profit before tax rose 7% to £49.7m...

  • 08 Sep
    07:17
    FLASH: Genus adjusted pre-tax profits up

    Story provided by StockMarketWire.com

  • 15 Aug
    11:57
    FTSE up as oil prices recover

    The FTSE 100 rose to 6,933 as oil prices rallied, while the FTSE 250 nudged lower to 17,896 despite increased footfall on the high street in July. West Texas Intermediate (WTI) crude oil advanced...

  • 15 Aug
    07:35
    Genus updates on US litigation

    Genus, a global pioneer in animal genetics, has reported the final jury verdicts in its litigation against Inguran LLC, operating as Sexing Technologies, relating to ABS's Genus Sexed Semen...

  • 15 Aug
    07:07
    FLASH: Genus updates on US litigation

    Story provided by StockMarketWire.com

  • 12 Aug
    16:50
    Higher oil prices support FTSE

    The FTSE 100 followed rallying oil prices higher at 6,920, after earlier struggling to stay in positive territory off the back of downbeat UK construction data. West Texas Intermediate (WTI) crude...

  • 12 Aug
    11:33
    Negative UK construction data fails to sway FTSE

    The FTSE 100 was stable at 6,922 despite UK construction data revealing a bigger decline than expected. West Texas Intermediate (WTI) crude oil was stable at $43.5, while Brent crude oil nudged...

  • 12 Aug
    07:59
    Genus updates on US litigation

    Genus has reported further jury verdicts in its litigation against Inguran LLC, operating as Sexing Technologies, relating to ABS's Genus Sexed Semen processing technology. At the trial, in the...

  • 12 Aug
    07:13
    FLASH: Genus updates on US litigation

    Story provided by StockMarketWire.com

  • 11 Aug
    07:54
    Genus updates on US anti-trust litigation

    Genus, a global pioneer in animal genetics, has announced the first jury verdicts in its anti-trust litigation against Inguran LLC, operating as Sexing Technologies ('ST'), relating to ABS's Genus...

  • 11 Aug
    07:09
    FLASH: Genus updates on US anti-trust litigation

    Story provided by StockMarketWire.com

  • 02 Aug
    08:00
    Broker Forecast - Peel Hunt issues a broker note on Genus PLC

    Peel Hunt today reaffirms its buy investment rating on Genus PLC (LON:GNS) and raised its price target to 2600p (from 1525p). Story provided by StockMarketWire.com

  • 27 Jul
    07:11
    Genus signs worldwide licence with WSU

    Genus signed an exclusive, worldwide licence with Washington State University (WSU) for patents and know how targeting bovine respiratory disease (BRD), using gene editing technology. BRD is a...

  • 18 May
    09:24
    Genus collaboration with Caribou Biosciences

    Genus and Caribou Biosciences have announced a multi-year strategic collaboration where Genus receives a worldwide, exclusive licence to Caribou's leading CRISPR-Cas9 gene editing technology...

  • 18 May
    07:15
    FLASH: Genus collaboration with Caribou Biosciences

    Story provided by StockMarketWire.com

  • 04 Mar
    09:41
    Unilever financial controller joins Genus board

    Genus, a leading global animal genetics company, has appointed Lysanne Gray to the board as non-executive director with effect from 1 April. Gray, a chartered accountant with a chemistry degree...

  • 23 Feb
    07:46
    Genus on track after solid H1

    Genus, a leading animal genetics company, reports solid first half results and says its full year is on track. Adjusted operating profits of GBP23.9m were 3% up at constant currencies but 2% at...

  • 23 Feb
    07:13
    FLASH: Genus on track after solid H1

    Story provided by StockMarketWire.com

  • 11 Dec
    17:05
    Director Deals - Genus PLC (GNS)

    Stephen Wilson, Financial Director, has re-invested 27 shares in the company on the 11th December 2015 at a price of 1455.50p. The Director now holds 3,098 shares. Story provided by...

  • 08 Dec
    09:38
    Genus tackles major pig disease

    Genus, a global pioneer in animal genetics, has announced the development of the first pigs resistant to Porcine Reproductive and Respiratory Syndrome Virus, through a long-standing collaboration...

  • 08 Dec
    07:14
    FLASH: Genus tackles major pig disease

    Story provided by StockMarketWire.com

  • 19 Nov
    14:59
    Genus resolutions passed at AGM

    Genus has confirmed that all resolutions proposed at its annual general meeting today were passed on a poll. At 2:59pm: (LON:GNS) Genus PLC share price was -11.5p at 1389.5p Story provided by...

  • 15 Oct
    13:09
    Genus schedules AGM

    Genus will hold its annual general meeting at Matrix House, Basing View, Basingstoke, Hampshire RG21 4DZ, on 19 November at 11.00 a.m. At 1:09pm: (LON:GNS) Genus PLC share price was -5p at...

  • 08 Sep
    14:16
    Genus adjusted pre-tax profits up

    Global animal genetics company Genus posts adjusted pre-tax profits of £46.6m for the year to the end of June - up from £39.3m last time and 23% higher at constant currencies. The increase was...

  • 29 Jun
    14:06
    Genus changes registered office

    Genus has changed its registered office address to Matrix House, Basing View, Basingstoke, Hampshire RG21 4DZ. At 2:06pm: (LON:GNS) Genus PLC share price was -2p at 1420p Story provided by...

  • 12 May
    09:40
    Genus on track

    Genus, a leading global animal genetics company, says it hasperformed in line with forecasts since the start of the year. Genus's volumes, revenues and adjusted profit before tax all increased...

  • 12 May
    07:18
    FLASH: Genus on track

    Story provided by StockMarketWire.com

  • 14 Apr
    15:00
    Director Deals - Genus PLC (GNS)

    Stephen Wilson, Executive Director, bought 12 shares in the company on the 14th April 2015 at a price of 1414.25p. The Director now holds 3,071 shares. Story provided by StockMarketWire.com...

  • 01 Apr
    09:21
    Genus completes acquisition of 51% of IVB

    Genus has completed the acquisition of 51% of In Vitro Brasil, a leading biotechnology company focused on the production of bovine embryos through in-vitro fertilisation and the provision of...

  • 24 Feb
    08:11
    Genus pre-tax profits up

    Genus - a leading animal genetics company - posts pre-tax profits of £24.7m for the six months to the end of December, up 20% at actual currencies and 26% on a constant currency basis. Revenues...

  • 24 Feb
    07:13
    FLASH: Genus pre-tax profits up

    Story provided by StockMarketWire.com

  • 16 Feb
    08:01
    Genus to acquire 51% of In Vitro Brasil

    Genus, a leading global animal genetics company, has signed an agreement for the acquisition of 51% of the share capital of In Vitro Brasil SA through ABS, its bovine genetics business. IVB is a...

  • 16 Feb
    07:13
    FLASH: Genus to acquire 51% of In Vitro Brasil SA

    Story provided by StockMarketWire.com

  • 12 Dec
    16:40
    Director Deals - Genus PLC (GNS)

    Stephen Wilson, Executive Director, has re-invested 27 shares in the company on the 11th December 2014 at a price of 1331.00p. The Director now holds 3,059 shares. Story provided by...

  • 14 Nov
    07:51
    Genus in line with forecasts

    Genus, a leading global animal genetics company, said it performed in line with expectations in the period from 1 July. Genus's volumes, revenues and adjusted profit before tax for the first...

  • 14 Nov
    07:15
    FLASH: Genus on track

    Story provided by StockMarketWire.com

  • 10 Sep
    13:57
    Genus upgraded by N+1

    Equity research analysts at N+1 Singer have upgraded their recommendation on animal genetics group Genus (LON:GNS) to ‘buy’ from ‘hold’, following the recent preliminary results and given...

  • 03 Sep
    08:25
    Genus in strategic agreement with Riverstone

    Genus, a leading global animal genetics company, has announced a new strategic agreement with River Stone Farm (Shandong) Co to become the group's first commercial multiplier in China....

  • 03 Sep
    07:44
    Genus revenues rise

    Genus, a leading global animal genetics company, posts adjusted pre-tax profits of £39.3m for the year to the end of June - 8% down on last year in actual currencies and flat on a constant...

  • 03 Sep
    07:15
    FLASH: Genus in strategic agreement with Riverstone

    Story provided by StockMarketWire.com

  • 03 Sep
    07:06
    FLASH: Genus revenues up

    Story provided by StockMarketWire.com

  • 09 Jun
    14:05
    Genus appoints general counsel and company secretary

    Genus, a leading global animal genetics company, has appointed Dan Hartley as group general counsel and company secretary with effect from 9 June. After being admitted to practice law in...

  • 27 May
    08:27
    Genus and Shennong will not proceed with JV

    Genus, a leading global animal genetics company, and Yunnan Shennong Agricultural Group Co have decided not to proceed with the establishment of a joint venture at the present time. Shennong, an...

  • 27 May
    07:31
    FLASH: Genus and Shennong will not proceed with JV

    Story provided by StockMarketWire.com

  • 15 May
    08:55
    Genus in strategic beef partnership with ABP

    Genus, a leading global animal genetics company, has agreed a strategic partnership with ABP Food Group, one of the largest beef processors in Europe. The multi-year agreement which aims to...

  • 15 May
    07:57
    Genus broadly in line with expectations

    Genus expects 2014 financial year results to be consistent with the pattern over the first 10 months, broadly in line with expectations. Market conditions for Genus's dairy and beef customers...

  • 15 May
    07:31
    FLASH: Genus in strategic beef partnership with ABP

    Story provided by StockMarketWire.com

  • 15 May
    07:03
    FLASH: Genus broadly in line with expectations

    Story provided by StockMarketWire.com

  • 03 Apr
    17:05
    Director Deals - Genus PLC (GNS)

    Bob Lawson, Chairman, bought 2,051 shares in the company on the 3rd April 2014 at a price of 975.00p. The Director now holds 7,201 shares. Story provided by StockMarketWire.com Director deals...

  • 03 Apr
    17:05
    Director Deals - Genus PLC (GNS)

    Karim Bitar, Chief Executive Officer, bought 3,045 shares in the company on the 3rd April 2014 at a price of 985.02p. The Director now holds 40,008 shares. Story provided by StockMarketWire.com...

  • 28 Mar
    14:55
    Director Deals - Genus PLC (GNS)

    Mike Buzzacott, Non Executive Director, bought 1,000 shares in the company on the 28th March 2014 at a price of 980.00p. The Director now holds 4,000 shares. Story provided by...

  • 19 Mar
    16:28
    Genus strengthens its board

    Genus, a leading global animal genetics company, has appointed Prof Duncan Maskell and Lykele van der Broek as non-executive directors with effect from 1 April and 1 July , respectively. Maskell...

  • 25 Feb
    08:12
    Genus revenues rise

    Genus - a leading animal genetics company - posts adjusted operating profits of £22.3m for the six months to the end of December. This was unchanged on an actual currency basis but up 2% at...

  • 25 Feb
    07:17
    FLASH: Genus operating profits rise

    Story provided by StockMarketWire.com

MoneyAM.com

MoneyAM

MoneyAM website is aimed at investors of all levels of experience including City professionals, investors and full-time traders.

  • Free live share prices
  • Free live watch lists
  • UK and Worldwide Indices
  • Live market News
  • Company Fundamentals
  • Charts - Intraday and historic
  • Stock Portfolio

Shares Magazine

Shares Magazine

Shares is the leading weekly publication for high net worth private investors and stock market professionals and as such is read weekly by thousands of private investors, analysts, fund managers, stockbrokers and company directors.

Special offer of 1 month for £1

Fantasy Investor

Fantasy Investor

Come and play Fantasy Investor and learn how to invest and see how much money you can make in shares, funds and ETFs without risking a penny. Play against other investors and build teams to compete in individual and team leagues.

Investor Events

Investor Events

Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.

Terms & Conditions | Privacy Policy | Cookies